Company
Headquarters: Herzliya, Israel
Employees: 75
CEO: Mr. Alexander Rabinovich
₪395.0 Million
ILS as of July 1, 2024
US$104.9 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
InterCure Ltd has the following listings and related stock indices.
Stock: TASE: INCR wb_incandescent
Stock: OTC: IRCLF wb_incandescent
Stock: NASDAQ: INCR wb_incandescent
Stock: TSX: INCR.U wb_incandescent